687
Views
11
CrossRef citations to date
0
Altmetric
Vaccine Profile

Fluarix quadrivalent vaccine for influenza

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Subhan Ullah & Ted M. Ross. (2022) Next generation live-attenuated influenza vaccine platforms. Expert Review of Vaccines 21:8, pages 1097-1110.
Read now
Riju Ray, Gaël Dos Santos, Philip O. Buck, Carine Claeys, Gonçalo Matias, Bruce L. Innis & Rafik Bekkat-Berkani. (2017) A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Human Vaccines & Immunotherapeutics 13:7, pages 1640-1652.
Read now
Won Suk Choi, Ji Yun Noh, Joon Young Song, Hee Jin Cheong, Seong-Heon Wie, Jin Soo Lee, Jacob Lee, Shin-Woo Kim, Hye Won Jeong, Sook-In Jung, Yeon-Sook Kim, Heung Jeong Woo, Kyung Ho Kim, Hun Kim & Woo Joo Kim. (2017) Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects. Human Vaccines & Immunotherapeutics 13:7, pages 1653-1660.
Read now

Articles from other publishers (8)

Rushit N. Lodaya, Amey P. Kanitkar, Asma Ashraf, Douty Bamba, Mansoor M. Amiji & Derek T. O’Hagan. (2023) A Self-Emulsified Adjuvant System Containing the Immune Potentiator Alpha Tocopherol Induces Higher Neutralizing Antibody Responses than a Squalene-Only Emulsion When Evaluated with a Recombinant Cytomegalovirus (CMV) Pentamer Antigen in Mice. Pharmaceutics 15:1, pages 238.
Crossref
Elodie Desuzinges Mandon, Andrés Pizzorno, Aurélien Traversier, Anne Champagne, Marie Eve Hamelin, Bruno Lina, Guy Boivin, Emmanuel Dejean, Manuel Rosa-Calatrava & Anass Jawhari. (2020) Novel calixarene-based surfactant enables low dose split inactivated vaccine protection against influenza infection. Vaccine 38:2, pages 278-287.
Crossref
Pilar Blanco-Lobo, Aitor Nogales, Laura Rodríguez & Luis Martínez-Sobrido. (2019) Novel Approaches for The Development of Live Attenuated Influenza Vaccines. Viruses 11:2, pages 190.
Crossref
Na Lei, Hai-bin Wang, Yu-song Zhang, Jian-hong Zhao, Yi Zhong, Yuan-jie Wang, Li-yong Huang, Jian-xin Ma, Qiang Sun, Lei Yang, Yue-long Shu, Shu-ming Li & Ling-li Sun. (2019) Molecular evolution of influenza B virus during 2011–2017 in Chaoyang, Beijing, suggesting the free influenza vaccine policy. Scientific Reports 9:1.
Crossref
José Antonio López Trigo, Rosa López Mongil, Alberto Mariano Lázaro, Gloria Mato Chaín, Norberto Moreno Villajos & Primitivo Ramos Cordero. (2018) Vacunación frente a la gripe estacional en las personas mayores. Evaluación de la vacuna tetravalente. Informe de posicionamiento. Revista Española de Geriatría y Gerontología 53, pages 185-202.
Crossref
Dominic Thorrington, Edwin van Leeuwen, Mary Ramsay, Richard Pebody & Marc Baguelin. (2017) Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England. BMC Medicine 15:1.
Crossref
Christiaan Dolk, Martin Eichner, Robert Welte, Anastassia Anastassopoulou, Laure-Anne Van Bellinghen, Barbara Poulsen Nautrup, Ilse Van Vlaenderen, Ruprecht Schmidt-Ott, Markus Schwehm & Maarten Postma. (2016) Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. PharmacoEconomics 34:12, pages 1299-1308.
Crossref
Marios Koutsakos, Thi HO Nguyen, Wendy S Barclay & Katherine Kedzierska. (2016) Knowns and unknowns of influenza B viruses. Future Microbiology 11:1, pages 119-135.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.